HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring. Han R, Madariaga A, Gonzalez-Ochoa E, Smith AC, et al. Int J Gynecol Pathol 2024 Mar 4. doi: 10.1097/PGP.0000000000000972.

Read + Share

Amedeo Smart

Independent Medical Education

Han R, Madariaga A, Gonzalez-Ochoa E, Smith AC, et al. HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring. Int J Gynecol Pathol 2024 Mar 4. doi: 10.1097/PGP.0000000000000972.
PMID: 38436360